NxStage Medical Inc.
NXTM
NXTM was delisted on the 21st of February, 2019.
111 hedge funds and large institutions have $721M invested in NxStage Medical Inc. in 2014 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 42 increasing their positions, 29 reducing their positions, and 17 closing their positions.
2,368% more call options, than puts
Call options by funds: $1.48M | Put options by funds: $60K
45% more repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 29
14% more funds holding in top 10
Funds holding in top 10: 7 → 8 (+1)
3% less funds holding
Funds holding: 115 → 111 (-4)
7% less capital invested
Capital invested by funds: $775M → $721M (-$54M)
24% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 17
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
+$16.7M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$8.38M |
| 3 |
RIM
RS Investment Management
San Francisco,
California
|
+$6.59M |
| 4 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
+$5.2M |
| 5 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
+$3.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
-$11.4M |
| 2 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$6.67M |
| 3 |
APG Asset Management
Amsterdam,
Netherlands
|
-$5.03M |
| 4 |
CM
Castleark Management
Chicago,
Illinois
|
-$4.68M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$2.87M |
NXTM Hedge Fund Activity: Q3 2014 in Review
111 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in NxStage Medical Inc. (NXTM) for Q3 2014, worth a combined $721M — down 7% from $775M a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of NXTM and 13 opened new positions — a net loss of 4 holders — while 29 trimmed existing stakes and 42 added.
The largest buyer was Deerfield Management, adding an estimated $16.7M. The largest seller was OrbiMed, exiting entirely with an estimated $11.4M sold.
- 111 institutional investors held NxStage Medical Inc. (NXTM) as of Q3 2014, down from 115 in Q2 2014.
- Funds reported $721M of NxStage Medical Inc. stock for Q3 2014, down 7% quarter-over-quarter.
- 13 funds opened new NxStage Medical Inc. positions in Q3 2014 and 17 closed out, a net change of -4 holders.
- The largest NxStage Medical Inc. buyer in Q3 2014 was Deerfield Management, an estimated $16.7M added.
- The largest NxStage Medical Inc. seller in Q3 2014 was OrbiMed, an estimated $11.4M sold.
Based on aggregated 13F filings for Q3 2014.